Nasus Pharma Ltd (NSRX)

Track

Over the last 90 days, Nasus Pharma Ltd. has seen two insider buy transactions totaling $41,504, exclusively by CEO Teleman Dan Benjamin. There were no sell transactions. This net buying activity, though small in absolute terms, represents a minor increase in insider ownership relative to the float.

Top insider buys (90, 60d)

Top executive buys (90, 60d)

Featured in screeners

Top insider buys

Top executive buys

Stock chart

Ticker: NSRX Exchange: ASE

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Teleman Dan Benjamin

Chief Executive Officer

1 purchase — total 10,904 USD

Buy 22 Apr 2026

Value US$3,175,341.60 | Price 252.02 | Shares 63,507

Teleman Dan Benjamin

Chief Executive Officer

1 purchase — total 30,600 USD

Buy 31 Mar 2026

Value US$4,662,376.09 | Price 233.00 | Shares 22,114

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-04-22	2026-04-22	B Purchase	Teleman Dan Benjamin Chief Executive Officer Executive Director	63,507 -18.0% 252.02 US$3,175,342	63,507 -18.0%	252.02	US$3,175,342
2026-04-01	2026-03-31	B Purchase	Teleman Dan Benjamin Chief Executive Officer Executive Director	22,114 -8.1% 233.00 US$4,662,376	22,114 -8.1%	233.00	US$4,662,376